July 22, 2008
Tranzyme Receives Notices of Allowance on Two Patents 
June 23, 2008
Tranzyme Announces Successful QT/QTc Study of TZP-101
June 17, 2008
Tranzyme’s TZP-102 Demonstrates Safety and High Oral Bioavailability
TZP-101 selected by Thomson Pharma as one of the five most promising Phase I drugs. Click here to read more.